ProPublica published a list of investigations you may have missed due to America's governing turmoil. One is the story of Zolgensma, a gene therapy drug which gives baby's born with a rare disease a real chance to grow up and live normal lives. Despite being developed with help from taxpayers and nonprofit charities, the drug's maker debuted the drug with a $2-million per dose price tag, which set the stage for other gene therapy drugs to also have million dollar prices. ProPublica dug into the records to show how the drug was developed and why it debuted at such a high cost. "Its story upends the widely held conception that high prices reflect huge industry investments in innovation."
Drudge Retort Headlines
America's Depleted Weapons Stocks in the Iran War Are a Strategic Red Flag (104 comments)
Trump's War Expected to Surge US Inflation (59 comments)
NY AG Letitia James Referred Again for Criminal Prosecution (30 comments)
Melania Trump Floats Replacing Teachers with Robots (29 comments)
The Worst Airport in America (26 comments)
Trump's Signature to Appear on US Dollars (25 comments)
Taxpayer Tab for Trump's Golf Habit Tops $100 Million (23 comments)
US Senator Calls Former USAG Merrick Garland a 'Coward' (19 comments)
Russia Sending Drones to Iran to Help War Effort, Western intelligence says (18 comments)
'No Kings' Rallies Draw Crowds Across U.S. (15 comments)